Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM)

Raffit Hassan; Evan Alley; Hedy Kindler; Scott Antonia; Thierry Jahan; Anish Thomas; Somayeh Honarmand; Aimee L Murphy; John J Grous; Dirk G Brockstedt

doi:10.1186/2051-1426-3-S2-P161

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Citation Tools

PDF

Poster Presentation

Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Hassan R, Alley E, Kindler H, et al

Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM)

Journal for ImmunoTherapy of Cancer 2015;3:P161. doi: 10.1186/2051-1426-3-S2-P161

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password